FIELD: medicine.
SUBSTANCE: invention relates to the field of medicine, namely to ophthalmology, and is intended for the treatment of inflammatory, viral, bacterial, allergic, metabolic, traumatic diseases. Eye drops consist of interferon, antihistamine, sodium hyaluronate, taurine, cyanocobalamin or hydroxocobalamin, sodium phosphate monobasic, boric acid, disodium edetate and water. Antihistamine is selected from the group: olopatadine, azelastine or levocabastine. Components are used in claimed amounts.
EFFECT: use of the invention provides complex therapy that exerts anti-inflammatory, antiviral, antiallergic, antimetabolite and regenerative effects.
1 cl, 1 tbl, 12 ex
| Title | Year | Author | Number |
|---|---|---|---|
| EYE GEL DROPS FOR TREATING ACUTE AND CHRONIC INFLAMMATORY EYE DISEASES CAUSED BY VIRAL, BACTERIAL, ALLERGIC, METABOLIC OR TRAUMATIC FACTORS | 2018 |
|
RU2692087C1 |
| THERAPEUTIC AGENT FOR TREATING ALLERGIC AND VIRAL OCULAR DISEASES IN FORM OF GEL OR GEL-LIKE DROPS | 2015 |
|
RU2595244C1 |
| GEL-LIKE EYE DROPS FOR TREATMENT OF INFLAMMATORY ALLERGIC, BACTERIAL, VIRAL, TRAUMATIC AND DYSTROPHIC EYE DISEASES | 2014 |
|
RU2561046C1 |
| OPHTHALMIC COMPOSITION OF EYE DROPS FOR TREATING ANTIBIOTIC-RESISTANT INFECTIOUS-INFLAMMATORY EYE DISEASES | 2014 |
|
RU2561049C1 |
| GEL EYE DROPS FOR CHRONIC AND ALLERGIC INFLAMMATORY DISEASES TREATMENT | 2016 |
|
RU2629590C1 |
| OPHTHALMIC COMPOSITION FOR TREATMENT OF CONJUNCTIVITES, BLEPARITIS AND MARGINAL CORNEAL ULCERS IN TOPICAL APPLICATION | 2016 |
|
RU2633055C1 |
| GEL PHARMACEUTICAL COMPOSITION FOR BLEPHARITIS TREATMENT | 2016 |
|
RU2633054C1 |
| OPHTHALMIC GEL COMPOSITION FOR TREATING CONJUNCTIVITIS, BLEPHARITIS, KERATITIS CORNEAL EROSION ASSOCIATED WITH INFLAMMATORY EYE DISEASES OF NON-INFECTIOUS OR POST-INFECTIOUS ETIOLOGY AND ALLERGIC LESIONS OF OCULAR SURFACE | 2014 |
|
RU2582284C1 |
| ANTIVIRAL AGENT - EYE DROPS | 2012 |
|
RU2473363C1 |
| EYE DROPS POSSESSING ANTIINFLAMMATORY AND ANTIBACTERIAL ACTION | 2012 |
|
RU2506086C1 |
